Answers are grounded in this paper and cite their sources.
This multicenter study compares treatment outcomes in spinal muscular atrophy type 1 patients, highlighting unclear benefits of combination therapy.
Early treatment is the main determinant of outcomes, while combination therapy shows no clear advantage over monotherapy. Larger prospective studies are needed to clarify the role and timing of combination therapy.
No takes yet. Share an insight, caveat, or question.
Genç et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: